Implications of the HELIX trial for treating infants with hypoxic-ischaemic encephalopathy in low-to-middle-income countries | ADC Fetal & Neonatal Edition

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via RCPCH

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

Podcasts

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens
Log in via RCPCH

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

Viewpoint

Implications of the HELIX trial for treating infants with hypoxic-ischaemic encephalopathy in low-to-middle-income countries

Online download statistics by month:

Online download statistics by month: February 2022 to March 2024

	Abstract	Full	Pdf
Feb 2022	822	63	33
Mar 2022	715	70	28
Apr 2022	430	14	17
May 2022	377	19	10
Jun 2022	432	29	17
Jul 2022	319	17	5
Aug 2022	355	18	11
Sep 2022	362	16	8
Oct 2022	334	14	6
Nov 2022	627	20	23
Dec 2022	680	47	34
Jan 2023	700	37	16
Feb 2023	375	22	15
Mar 2023	112	17	11
Apr 2023	116	9	9
May 2023	183	12	10
Jun 2023	83	10	4
Jul 2023	90	11	7
Aug 2023	129	9	3
Sep 2023	69	10	10
Oct 2023	63	7	4
Nov 2023	113	7	6
Dec 2023	278	10	8
Jan 2024	110	7	6
Feb 2024	100	6	4
Mar 2024	92	5	5
Total	8066	506	310